Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan

N Engl J Med. 2015 Dec 3;373(23):2289-90. doi: 10.1056/NEJMc1509753.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aminobutyrates / therapeutic use*
  • Angiotensin Receptor Antagonists / therapeutic use*
  • Biphenyl Compounds
  • Cause of Death
  • Drug Combinations
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Kaplan-Meier Estimate
  • Life Expectancy
  • Middle Aged
  • Tetrazoles / therapeutic use*
  • Valsartan / therapeutic use

Substances

  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • sacubitril and valsartan sodium hydrate drug combination